Clinical Trial Update: Dose Ranging Study of Carbidopa-levodopa [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging study of carbidopa-levodopa for age-related macular degeneration has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• carbidopa-levodopa (carbidopa-levodopa)

Snippet

Sponsor: Snyder, Robert W., M.D., Ph.D., P.C. | Conditions: Age-related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2025-09-12